Jennifer Juhl Majersik, MD, MS

Journal Article

1. Ken-Dror G, Cotlarciuc I, Martinelli I, Grandone E, Hiltunen S, Lindgren E, Margaglione M, Duchez VLC, Triquenot AB, Zedde M, Mancuso M, Ruigrok YM, Marjot T, Worrall B, Majersik JJ, Metso TM, Putaala J, Haapaniemi E, Zuurbier SM, Brouwer MC, Passamonti SM, Abbattista M, Bucciarelli P, Mitchell BD, Kittner SJ, Lemmens R, Jern C, Pappalardo E, Costa P, Colombi M, de Sousa DA, Rodrigues S, Canho P, Tkach A, Santacroce R, Favuzzi G, Arauz A, Colaizzo D, Spengos K, Hodge A, Ditta R, Pezzini A, Debette S, Coutinho JM, Thijs V, Jood K, Pare G, Tatlisumak T, Ferro JM, Sharma P, International Stroke Genetics Consortium ISGC Bio-Repository to Establish the Aetiology of Sinovenous Thrombosis BEAST collaborators (2021). Genome-wide association study identifies first locus associated with susceptibility to cerebral venous thrombosis. (Epub ahead of print) Ann Neurol.
2. Khnlein P, Mahnkopf C, Majersik JJ, Wilson BD, Mitlacher M, Tirschwell D, Longstreth WT Jr, Akoum N (2021). Atrial fibrosis in embolic stroke of undetermined source: A multicenter study. (Epub ahead of print) Eur J Neurol.
3. de Havenon A, Delic A, Yaghi S, Wong KH, Majersik JJ, Stulberg E, Tirschwell D, Anadani M (2021). Midlife Blood Pressure Variability and Risk of All-Cause Mortality and Cardiovascular Events During Extended Follow-Up. (Epub ahead of print) Am J Hypertens.
4. Bossart A, McClune B, Barrell K, Warner J, Majersik JJ (2021). Pearls & Oy-sters: POEMS Syndrome: An Eloquent Acronym for a Rare Disease You Don't Want to Miss. (Epub ahead of print) Neurology.
5. de Havenon A, Tirschwell DL, Heitsch L, Cramer SC, Braun R, Cole J, Reddy V, Majersik JJ, Lindgren A, Worrall BB (2020). Variability of the Modified Rankin Scale Score Between Day 90 and 1 Year After Ischemic Stroke. Neurol Clin Pract, 11(3), e239-e244.
6. de Havenon A, Ney JP, Callaghan B, Hohmann S, Shippey E, Yaghi S, Anadani M, Majersik JJ (2021). Characteristics and Outcomes Among US Patients Hospitalized for Ischemic Stroke Before vs During the COVID-19 Pandemic. JAMA Netw Open, 4(5), e2110314.
7. Majersik JJ, Ahmed A, Chen IA, Shill H, Hanes GP, Pelak VS, Hopp JL, Omuro A, Kluger B, Leslie-Mazwi T (2021). A Shortage of Neurologists We Must Act Now: A Report From the AAN 2019 Transforming Leaders Program. (Epub ahead of print) Neurology.
8. Ravindra VM, Grandhi R, Delic A, Hohmann S, Shippey E, Tirschwell D, Frontera JA, Yaghi S, Majersik JJ, Anadani M, de Havenon A (2021). Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States. PLoS ONE, 16(4), e0248728.
9. Kashida YT, Garcia-Esperon C, Lillicrap T, Miteff F, Garcia-Bermejo P, Gangadharan S, Chew BLA, OBrien W, Evans J, Alanati K, Bivard A, Parsons M, Majersik JJ, Spratt NJ, Levi C, members of Northern NSW Telestroke investigators for this project (2021). The Need for Structured Strategies to Improve Stroke Care in a Rural Telestroke Network in Northern New South Wales, Australia: An Observational Study. Front Neurol, 12, 645088.
10. Lindgren A, Braun R, Majersik JJ, Clatworthy P, Mainali S, Derdeyn CP, Maguire JM, Jern C, Rosand J, Cole JW, Lee JM, Khatri P, Nyquist PA, Debette SP, Keat Wei L, Rundek T, Leifer D, Thijs V, Lemmens R, Heitsch L, Prasad K, Jimenez-Conde J, Dichgans M, Rost NS, Cramer SC, Bernhardt J, Worrall BB, Cadenas I (2021). EXPRESS: International Stroke Genetics Consortium Recommendations for Studies of Genetics of Stroke Outcome and Recovery. Int J Stroke, 17474930211007288.
11. Bailey RR, Singleton JR, Majersik JJ (2021). Association of obesity and diabetes with physical activity and fruit and vegetable consumption in stroke survivors. Fam Pract, 38(1), 56-61.
12. Poon JT, Tkach A, Havenon AH, Hoversten K, Johnson J, Hannon PM, Chung LS, Majersik JJ (2021). Telestroke consultation can accurately diagnose ischemic stroke mimics. J Telemed Telecare, 1357633X21989558.
13. de Havenon A, Ney JP, Callaghan B, Delic A, Hohmann S, Shippey E, Esper GJ, Stulberg E, Tirschwell D, Frontera J, Yaghi S, Anadani M, Majersik JJ (2020). Impact of COVID-19 on Outcomes in Ischemic Stroke Patients in the United States. Journal of Stroke and Cerebrovascular Diseases, 30(2), 105535.
14. Tekiela P, Majersik JJ (2021). The Impact of COVID-19 on Developing Neurologic Disorders. Neurology, 96(4), e647-e649.
15. Majersik JJ (2021). Reader Response: Neuro R2 Score: Predicting High-Risk Neurologic Readmissions Within 30 Days. Neurology, 96(2), 84.
16. Baradaran H, Delic A, Wong KH, Sheibani N, Alexander M, McNally JS, Majersik JJ, De Havenon A (2021). Using Ultrasound and Inflammation to Improve Prediction of Ischemic Stroke: A Secondary Analysis of the Multi-Ethnic Study of Atherosclerosis. Cerebrovasc Dis Extra, 11(1), 37-43.
17. Wong KH, Hu K, Peterson C, Sheibani N, Tsivgoulis G, Majersik JJ, de Havenon AH (2020). Diabetic Retinopathy and Risk of Stroke: A Secondary Analysis of the ACCORD Eye Study. Stroke, 51(12), 3733-3736.
18. Goldstein ED, Shakoor A, Majersik JJ (2020). Branch Retinal Vein Occlusion and Venous Abnormalities in CADASIL. Neurologist, 25(6), 178-179.
19. Zha AM, Chung LS, Song SS, Majersik JJ, Jagolino-Cole AL (2020). Training in Neurology: Adoption of resident teleneurology training in the wake of COVID-19: Telemedicine crash course. Neurology, 95(9), 404-407.
20. Leira EC, Russman AN, Biller J, Brown DL, Bushnell CD, Caso V, Chamorro A, Creutzfeldt CJ, Cruz-Flores S, Elkind MSV, Fayad P, Froehler MT, Goldstein LB, Gonzales NR, Kaskie B, Khatri P, Livesay S, Liebeskind DS, Majersik JJ, Moheet AM, Romano JG, Sanossian N, Sansing LH, Silver B, Simpkins AN, Smith W, Tirschwell DL, Wang DZ, Yavagal DR, Worrall BB (2020). Preserving stroke care during the COVID-19 pandemic: Potential issues and solutions. Neurology, 95(3), 124-133.
21. Goldstein ED, Majersik JJ, McNally S (2020). Intracranial high-resolution vessel wall imaging in CADASIL. Neurology, 94(23), 1040-1041.
22. Traenka C, Grond-Ginsbach C, Goeggel Simonetti B, Metso TM, Debette S, Pezzini A, Kloss M, Majersik JJ, Southerland AM, Leys D, Baumgartner R, Caso V, Bjot Y, De Marchis GM, Fischer U, Polymeris A, Sarikaya H, Thijs V, Worrall BB, Bersano A, Brandt T, Gensicke H, Bonati LH, Touze E, Martin JJ, Chabriat H, Tatlisumak T, Arnold M, Engelter ST, Lyrer P, CADISP-Plus Study Group (2019). Artery occlusion independently predicts unfavorable outcome in cervical artery dissection. Neurology, 94(2), e170-e180.
23. de Havenon A, Chung LS, Smith J, Taylor K, Majersik JJ, Chauhan N (2019). Less Experienced Telestroke Consultants Are More Likely to Go On-Camera, but Less Likely to Give tPA. Stroke Res Treat, 2019, 1059369.
24. de Havenon A, Fino NF, Johnson B, Wong KH, Majersik JJ, Tirschwell D, Rost N (2019). Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of PRoFESS. Stroke, 50(11), 3170-3176.
25. de Havenon A, Wong KH, Elkhetali A, McNally JS, Majersik JJ, Rost NS (2019). Carotid Artery Stiffness Accurately Predicts White Matter Hyperintensity Volume 20 Years Later: A Secondary Analysis of the Atherosclerosis Risk in the Community Study. AJNR Am J Neuroradiol, 40(8), 1369-1373.
26. Majersik JJ (2019). Ethics and Bias in Clinical Trial Enrollment in Stroke. Curr Cardiol Rep, 21(6), 49.
27. Touz E, Southerland AM, Boulanger M, Labeyrie PE, Azizi M, Bouatia-Naji N, Debette S, Gornik HL, Hussain SM, Jeunemaitre X, Joux J, Kirton A, Le Hello C, Majersik JJ, Mocco J, Persu A, Sharma A, Worrall BB, Olin JW, Plouin PF (2018). Fibromuscular Dysplasia and Its Neurologic Manifestations: A Systematic Review. JAMA Neurol, 76(2), 217-226.
28. de Havenon A, Tirschwell D, Majersik JJ, McNally S, Stoddard G, Moore A, Mossa-Basha M (2017). Carotid intraplaque hemorrhage on vessel wall MRI does not correlate with TCD emboli monitoring in patients with recently symptomatic carotid atherosclerosis. Neuroradiol J, 30(5), 486-489.
29. McNally JS, Burton TM, Aldred BW, Kim SE, McLaughlin MS, Eisenmenger LB, Stoddard GJ, Majersik JJ, Miller DV, Treiman GS, Parker DL (2016). Vitamin D and Vulnerable Carotid Plaque. AJNR Am J Neuroradiol, 37(11), 2092-2099.
30. Nelson RE, Okon N, Lesko AC, Majersik JJ, Bhatt A, Baraban E (2015). The cost-effectiveness of telestroke in the Pacific Northwest region of the USA. J Telemed Telecare, 22(7), 413-21.
31. Sangle N, Baringer JR, Majersik J, DeWitt LD (2015). CADASIL with Multiorgan Involvement: a Complete Autopsy Examination Report. Can J Neurol Sci, 43(1), 202-5.
32. de Havenon A, Moore A, Sultan-Qurraie A, Majersik JJ, Stoddard G, Tirschwell D (10/06/2015). Ischemic stroke patients with active malignancy or extracardiac shunts are more likely to have a right-to-left shunt found by TCD than echocardiogram. Transl Stroke Res, 6(5), 361-4.
33. de Havenon A, Moore A, Sultan-Qurraie A, Majersik JJ, Stoddard G, Tirschwell D (2015). Ischemic stroke patients with active malignancy or extracardiac shunts are more likely to have a right-to-left shunt found by TCD than echocardiogram. Transl Stroke Res, 6(5), 361-4.
34. Sardar P, Chatterjee S, Giri J, Kundu A, Tandar A, Sen P, Nairooz R, Huston J, Ryan JJ, Bashir R, Parikh SA, White CJ, Meyers PM, Mukherjee D, Majersik JJ, Gray WA (2015). Endovascular therapy for acute ischaemic stroke: a systematic review and meta-analysis of randomized trials. Eur Heart J, 36(35), 2373-80.
35. Debette S, Compter A, Labeyrie MA, Uyttenboogaart M, Metso TM, Majersik JJ, Goeggel-Simonetti B, Engelter ST, Pezzini A, Bijlenga P, Southerland AM, Naggara O, Bjot Y, Cole JW, Ducros A, Giacalone G, Schilling S, Reiner P, Sarikaya H, Welleweerd JC, Kappelle LJ, de Borst GJ, Bonati LH, Jung S, Thijs V, Martin JJ, Brandt T, Grond-Ginsbach C, Kloss M, Mizutani T, Minematsu K, Meschia JF, Pereira VM, Bersano A, Touz E, Lyrer PA, Leys D, Chabriat H, Markus HS, Worrall BB, Chabrier S, Baumgartner R, Stapf C, Tatlisumak T, Arnold M, Bousser MG (2015). Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection. Lancet Neurol, 14(6), 640-54.
36. Majersik JJ (2014). Comment: Nickel-associated delayed cerebral hypersensitivity- Recognition is key. Neurology, 84(1), 97.
37. Walker KA, Sampson JB, Skalabrin EJ, Majersik JJ (2013). Clinical characteristics and thrombolytic outcomes of infective endocarditis-associated stroke. Neurohospitalist, 2(3), 87-91.
38. Nelson RE, Saltzman GM, Skalabrin EJ, Demaerschalk BM, Majersik JJ (2011). The cost-effectiveness of telestroke in the treatment of acute ischemic stroke. Neurology, 77(17), 1590-8.
39. Cantu-Brito C, Majersik JJ, Snchez BN, Ruano A, Becerra-Mendoza D, Wing JJ, Morgenstern LB (2011). Door-to-door capture of incident and prevalent stroke cases in Durango, Mexico: the Brain Attack Surveillance in Durango Study. Stroke, 42(3), 601-6.
40. Arsava EM, Ballabio E, Benner T, Cole JW, Delgado-Martinez MP, Dichgans M, Fazekas F, Furie KL, Illoh K, Jood K, Kittner S, Lindgren AG, Majersik JJ, Macleod MJ, Meurer WJ, Montaner J, Olugbodi AA, Pasdar A, Redfors P, Schmidt R, Sharma P, Singhal AB, Sorensen AG, Sudlow C, Thijs V, Worrall BB, Rosand J, Ay H, International Stroke Genetics Consortium (2010). The Causative Classification of Stroke system: an international reliability and optimization study. Neurology, 75(14), 1277-84.
41. Arsava EM, Ballabio E, Benner T, Cole JW, Delgado-Martinez MP, Dichgans M, Fazekas F, Furie KL, Illoh KL, Jood K, Kittner S, Lindgren AG, Majersik JJ, Macleod MJ, Meurer WJ, Montaner JJ, Olugbodi AA, Pasdar A, Redfors P, Schmidt R, Sharma P, Singhal AB, Sorensen AG, Sudlow C, Thijs V, Worrall BB, Rosand J, Ay H and On behalf of the International Stroke Genetics Consortium (2010). The Causative Classification of Stroke System: An International Reliability and Optimization Study. Neurology, 75, 1277–1284.
42. Meurer WJ, Scott PA, Caveney AF, Majersik JJ, Frederiksen SM, Sandretto A, Holden AB, Silbergleit R (2010). Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator. Int J Stroke, 5(3), 163-6.
43. Cantu-Brito C, Majersik JJ, Snchez BN, Ruano A, Quiones G, Arzola J, Morgenstern LB (2010). Hospitalized stroke surveillance in the community of Durango, Mexico: the brain attack surveillance in Durango study. Stroke, 41(5), 878-84.
44. Cantu-Brito C, Majersik JJ, Snchez BN, Ruano A, Quiones G, ArzolaJ, Morgenstern LB (05/01/2010). Hospitalized Stroke Surveillance in the Community of Durango, Mexico – the Brain Attack Surveillance in Durango (BASID) Study. Stroke, 41(5), 878-884.
45. Mullen Conley K, Juhl Majersik J, Gonzales NR, Maddox KE, Pary JK, Brown DL, Moye LA, Espinosa N, Grotta JC, Morgenstern LB (2010). Kids Identifying and Defeating Stroke (KIDS): development and implementation of a multiethnic health education intervention to increase stroke awareness among middle school students and their parents. Health Promotion Practice, 11(1), 95-103.
46. Lisabeth LD, Brown DL, Hughes R, Majersik JJ, Morgenstern LB (2009). Acute stroke symptoms: comparing women and men. Stroke, 40(6), 2031-6.
47. Brown DL, Zahuranec DB, Majersik JJ, Wren PA, Gruis KL, Zupancic M, Lisabeth LD (2009). Risk of sleep apnea in orchestra members. Sleep Med, 10(6), 657-60.
48. Lisabeth LD, Brown DL, Hughes R, Majersik JJ, Morgenstern LB (2009). Acute stroke symptoms: comparing women and men. Stroke, 40(6), 2031-6.
49. Meurer WJ, Snchez BN, Smith MA, Lisabeth LD, Majersik JJ, Brown DL, Uchino K, Bonikowski FP, Mendizabal JE, Zahuranec DB, Morgenstern LB (2008). Predicting ischaemic stroke subtype from presenting systolic blood pressure: the BASIC Project. J Intern Med, 265(3), 388-96.
50. Meurer WJ, Sanchez BN, Smith MA, Lisabeth LD, Majersik JJ, Brown DL, Uchino K, Bonikowski FP, Mendizabal JE, Zahuranec DB, Morgenstern LB (2009). Predicting ischaemic stroke subtype from presenting systolic blood pressure: the BASIC Project. J Intern Med, 265(3), 388-96.
51. Lisabeth LD, Escobar JD, Dvonch JT, Snchez BN, Majersik JJ, Brown DL, Smith MA, Morgenstern LB (2008). Ambient air pollution and risk for ischemic stroke and transient ischemic attack. Ann Neurol, 64(1), 53-9.
52. Majersik JJ, Silbergleit R, Meurer WJ, Brown DL, Lisabeth LD, Morgenstern LB (2008). Public health impact of full implementation of therapeutic hypothermia after cardiac arrest. Resuscitation, 77(2), 189-94.
53. Brown DL, Morgenstern LB, Majersik JJ, Kleerekoper M, Lisabeth LD (2008). Risk of fractures after stroke. Cerebrovasc Dis, 25(1-2), 95-9.
54. Lisabeth LD, Peyser PA, Long JC, Majersik JJ, Smith MA, Morgenstern LB (2008). Stroke Among Siblings in a Bi-ethnic Community. Neuroepidemiology, 31, 33-38.
55. Majersik JJ, Smith MA, Zahuranec DB, Snchez BN, Morgenstern LB (2007). Population-based analysis of the impact of expanding the time window for acute stroke treatment. Stroke, 38(12), 3213-7.
56. Majersik JJ, Smith MA, Zahuranec DB, Sanchez BN, Morgenstern LB (2007). Population-based analysis of the impact of expanding the time window for acute stroke treatment. Stroke, 38(12), 3213-7.
57. Meurer WJ, Frederiksen SM, Majersik JJ, Zhang L, Sandretto A, Scott PA (2007). Qualitative data collection and analysis methods: the INSTINCT trial. Acad Emerg Med, 14(11), 1064-71.
58. Majersik JJ, Caravati EM, Steffens JD (2007). Severe neurotoxicity associated with exposure to the solvent 1-bromopropane (n-propyl bromide). Clin Toxicol (Phila), 45(3), 270-6.
59. Pribble JM, Goldstein KM, Majersik JJ, Barsan WG, Brown DL, Morgenstern LB (2006). Stroke information reported on local television news: a national perspective. Stroke, 37(6), 1556-7.
60. Pribble JM, Goldstein KM, Majersik JJ, Barsan WG, Brown DL, Morgenstern LB (2006). Stroke information reported on local television news: a national perspective. Stroke, 37(6), 1556-7.
61. Majersik JJ, Skalabrin EJ (2006). Single-gene stroke disorders. Semin Neurol, 26(1), 33-48.

Book Chapter

1. Southerland A, Majersik JJ, Worrall BB (04/29/2015). Chapter 15: Cervical Artery Dissection. In Gilbert R. Upchurch Jr., Peter K. Henke (Eds.), Clinical Scenarios in Vascular Surgery, Second Edition. LWW.

Editorial

1. Muir KW, Majersik JJ (2021). Connecting Upper Limb Functional Stroke Recovery to Global Disability Measures: Finding the Forest in the Trees. Neurology, 96(14), 643-644.
2. Majersik JJ, Reddy VK (2020). Acute neurology during the COVID-19 pandemic: Supporting the front line. Neurology, 94(24), 1055-1057.
3. Majersik JJ, Woo D (2020). The enormous financial impact of stroke disability. Neurology, 94(9), 377-378.
4. Fletcher JJ, Majersik JJ (2016). Stroke systems of care: The sum is greater than the parts. Neurology, 86(10), 886-7.
5. Majersik JJ (2015). Doctor, did stress cause my stroke? Neurology, 85(19), 1640-1.
6. Majersik JJ (10/14/2015). Doctor: Did Stress Cause My Stroke? Neurology, 85, 1-2.
7. Majersik JJ, Schmidt RH (2015). Continued risk of SAH after negative screen in first-degree relatives--and persistent questions. Neurology, 84(9), 868-9.
8. Majersik JJ, Schmidt RH (03/03/2015). Continued risk of SAH after negative screen in first degree relatives - and persistent questions. Invited editorial on Rasing I, et al. Longterm risk of subarachnoid hemorrhage after a negative aneurysm screen. Neurology, 84(9), 868-9.
9. Majersik JJ, Cole JW, Golledge J, Rost NS, Chan YF, Gurol ME, Lindgren AG, Woo D, Fernandez-Cadenas I, Chen DT, Thijs V, Worrall BB, Kamal A, Bentley P, Wardlaw JM, Ruigrok YM, Battey TW, Schmidt R, Montaner J, Giese AK, Roquer J, Jimnez-Conde J, Lee C, Ay H, Martin JJ, Rosand J, Maguire J, International Stroke Genetics Consortium (2014). Recommendations from the international stroke genetics consortium, part 1: standardized phenotypic data collection. Stroke, 46(1), 279-84.
10. Battey TW, Valant V, Kassis SB, Kourkoulis C, Lee C, Anderson CD, Falcone GJ, Jimenez-Conde J, Fernandez-Cadenas I, Pare G, Rundek T, James ML, Lemmens R, Lee TH, Tatlisumak T, Kittner SJ, Lindgren A, Mateen FJ, Berkowitz AL, Holliday EG, Majersik J, Maguire J, Sudlow C, Rosand J, International Stroke Genetics Consortium (2014). Recommendations from the international stroke genetics consortium, part 2: biological sample collection and storage. Stroke, 46(1), 285-90.

Letter

1. de Havenon A, Ney JP, Callaghan B, Yaghi S, Majersik JJ (2020). Excess neurological death in New York City after the emergence of COVID-19. [Letter to the editor]. J Neurol, 268(6), 2026-2028.
2. de Havenon A, Yaghi S, Majersik JJ, Hohmann S, Ney JP, Callaghan B, Anadani M (2021). Acute Coronary Syndrome and Ischemic Stroke Discharges in the United States During the COVID-19 Pandemic. [Letter to the editor]. Stroke, 52(6), e239-e241.

Abstract

1. McNally JS, Aldred B, Burton T, McLauglin M, Kim S, Miller D, Majersik J, Parker D, Treiman G (2015). Vitamin D and Vulnerable Carotid Plaque. Accepted for oral presentation at the American Society of Neuroradiology, Chicago, USA, 2015. [Abstract]. AJNR.
2. de Havenon A, Stoddard G, Wang H, Chung L, Majersik JJ (May 2015). Increased blood pressure variable is associated with worse outcome in acute ischemic stroke patients with penumbra. Accepted for oral presentation at the European Stroke Conference, Vienna, Austria, May 2015. [Abstract]. Cerebrovascular Diseases.
3. Krug A, Ramirez L, Nhoung H, Perese J, Gasparian G, Kazaryan S, Kelly C, Breen J, Majersik JJ, Sanossian N (02/12/2015). A Survey of Certified Stroke Center Medical Directors in the United States. Poster Board Number: P283. Accepted as a poster to the International Stroke Conference, February 11-13, 2015, Nashville, TN, USA [Abstract]. Stroke.
4. Nelson R, Lesko A, Majersik J, Okon N, Bhatt A, Baraban E (2/12/2015). Budget Impact Analysis of Telestroke in the Pacific Northwest, Abstract, # 3732. Accepted for poster presentation at the International Stroke Conference February 11 - 13, 2015, Nashville, TN, USA [Abstract]. Stroke.
5. Okon N, Nelson R, Majersik J, Lesko A, Bhatt A, Baraban E (2/11/2015). Telestroke Network Cost-Effectiveness in the Pacific Northwest: Geography and Facility Size Support a Cost-Sharing Model Between Hub and Spoke, Abstract #3176. Accepted as a moderated poster presentation to the International Stroke Conference, February 11 - 13, 2015, Nashville, TN, USA. [Abstract]. Stroke.
6. Baraban E, Nelson R, Lesko A, Majersik J, Bhatt A, Okon (2/11/2015). The Cost-Effectiveness of Telestroke Varies by Implementation Cost and Stroke Severity: Real World Data From a Pacific Northwest Network, Abstract # 3665. ccepted for poster presentation at the International Stroke Conference, February 11 - 13, 2015, Nashville, TN, USA [Abstract]. Stroke.
7. Majersik JJ, Cannon-Albright L (2012). Large Pedigrees at High Risk of Early Stroke Death [Abstract].
8. Majersik JJ, Jex RF, Skalabrin EJ, Taillac PP (May 2012). Development and Initial Results of an Inclusive State-Wide Approach to Stroke Care [Abstract]. Quality Care and Outcomes Research in Cardiovascular Disease and Stroke 2012 Scientific Sessions, Atlanta, GA.
9. Southerland AM, Malik S, Majersik JJ, Worrall BB (2/1/2011). Age Distribution by Sex and Clinical Characteristic in Cervical Artery Dissection. Presented in poster form at the American Academy of Neurology annual meeting, Honolulu, HI, USA [Abstract].
10. Majersik JJ, Cannon-Albright LA (2010). Evidence for a Heritable Contribution to Death from Ischemic Stroke. American Academy of Neurology, Toronto, Canada. [Abstract].
11. Nelson RE, Saltzman G, Skalabrin EJ, Majersik JJ (2010). Cost-Effectiveness of Telestroke for Ischemic Stroke: A Literature-Based Decision-Analytic Model. International Stroke Conference, San Antonio, TX, USA [Abstract].
12. Cantu CB, Majersik JJ, Sanchez BS, Morgenstern LB (2009). Physician Perception of Acute Stroke Care in a Mexican Community, American Academy of Neurology, Seattle, WA, USA. [Abstract].

Other

1. de Havenon A, Ney J, Callaghan B, Delic A, Hohmann S, Shippey E, Yaghi S, Anadani M, Esper G, Majersik J (2020). A Rapid Decrease in Stroke, Acute Coronary Syndrome, and Corresponding Interventions at 65 United States Hospitals Following Emergence of COVID-19. United States.
2. Majersik JJ, Meurer WJ (2007). The 2007 International Stroke Conference San Francisco, California February 7-9, 2007. J Neuroophthalmol (27(2), pp. 147-9). United States.
3. Zahuranec DB, Majersik JJ (2006). The 2006 International Stroke Conference Orlando, Florida, February 15-18, 2006. J Neuroophthalmol (26(2), pp. 156-7). United States.